SCHEMBL13075992

SCHEMBL13075992

Cc1nc2ccc(NC=O)cc2s1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LDHA P00338 2/20 0.61
KDM4E B2RXH2 3/20 0.57
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
SMN1; SMN2 Q16637 11/20 0.57
RAB9A P51151 8/20 0.57
NPC1 O15118 6/20 0.57
HTT P42858 5/20 0.55
LMNA P02545 4/20 0.55
ALDH1A1 P00352 1/20 0.54
MAPT P10636 2/20 0.53
GAA P10253 2/20 0.53
PKM P14618 1/20 0.52
NOD2 Q9HC29 1/20 0.52
HSD17B10 Q99714 1/20 0.51
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24862884 0.87 KMT2A (0.57) LDHAKMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL10477984 0.81 LDHA (0.40) LDHAKDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL9722764 0.81 EPHX2 (0.55) KDM4EKMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL4503667 0.80 KDM4E (0.64) LDHAKDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL12312871 0.79 APP (0.41) LDHAKDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL23451238 0.79 KDM4E (0.52) LDHAKDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL12907 0.78 LDHA (0.62) LDHAKDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL4664159 0.77 LDHA (0.80) LDHAKDM4EKMT2ASMN1; SMN2RAB9A
SCHEMBL14380470 0.77 LDHA (0.61) LDHAKDM4EKMT2AMEN1SMN1; SMN2
SCHEMBL15866384 0.77 LDHA (0.57) LDHAKDM4EKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377642-B1 COLORING COMPOSITION FOR IMAGE FORMATION AND METHOD FOR IMPROVING OZONE RESISTANCE OF COLOR IMAGE FUJIFILM CORP (JP) 2013-01-09 EP disclosed
WO-2010130034-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-18 WO disclosed